Skip to main content

Advertisement

SpringerLink
Log in

Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury

  • Urology – Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

To present a comprehensive experience of botulinum toxin A (BTX-A) injected into the detrusor muscle in patients with spinal cord injuries (SCI) causing neurogenic detrusor overactivity.

Methods

Three hundred units of BTX-A were injected cystoscopically into the detrusor muscle of 108 patients with neurogenic detrusor overactivity secondary to SCI at 30 different locations. Evaluations were performed before the injections and 6 weeks after, and they included determination of bladder urinary continence status, frequency/volume chart of CIC, concomitant anticholinergic medication use, Incontinence Quality of Life questionnaire (I-QOL) and patient satisfaction. Key urodynamic parameters (reflex volume, maximum detrusor pressure during voiding, detrusor compliance and maximum cystometric capacity) were analyzed at the outset and during the follow-up (6, 12 and 36 weeks) examinations.

Results

By the time of the urodynamic follow-up examinations (6, 12 and 36 weeks), the mean cystometric capacity (P < 0.05) and the mean reflex volume (P < 0.05) increased significantly, while the mean voiding pressure (P < 0.05) decreased significantly. No complications or side effects were reported. Most patients considerably reduced or even stopped taking anticholinergic drugs and were satisfied with the treatment.

Conclusions

This retrospective study indicates that BTX-A injections into the detrusor muscle to treat neurogenic detrusor overactivity secondary to SCI are safe and valuable. Significant improvement of bladder function corresponded with continence and subjective satisfaction indicated by the treated patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sekhon LH, Fehlings MG (2001) Epidemiology,demographics, and pathophysiology of acute spinal cord injury. Spine 26(24 Suppl):S2–S12

    Article  PubMed  CAS  Google Scholar 

  2. Riccabona M, Koen M, Schindler M et al (2004) Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171:845–848

    Article  PubMed  CAS  Google Scholar 

  3. Schurch B, Stohrer M, Kramer G et al (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692–697

    Article  PubMed  CAS  Google Scholar 

  4. Lacy DB, Tepp W, Cohen AC et al (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5:898–902

    Article  PubMed  CAS  Google Scholar 

  5. de Paiva A, Meunier FA, Molgo J et al (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 96:3200–3205

    Article  PubMed  Google Scholar 

  6. Stohrer M, Schurch B, Kramer G et al (1999) Botulinum A toxin in the treatment of detrusor hyperreflexia in spinal cord injury. A new alternative to medical and surgical procedures? Neurourol Urodyn 18:401–402

    Article  Google Scholar 

  7. Rieder CR, Schestatsky P, Socal MP et al (2007) A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm. Clin Neuropharmacol 30:39–42

    Article  PubMed  Google Scholar 

  8. Quagliato EM, Carelli EF, Viana MA (2010) Prospective, randomized, double-blind study, comparing botulinum toxins type A botox and prosigne for blepharospasm and hemifacial spasm treatment. Clin Neuropharmacol 33:27–31

    PubMed  CAS  Google Scholar 

  9. Maynard FM Jr, Bracken MB, Creasey G et al (1997) International standards for neurological and functional classification of spinal cord injury. American spinal injury association. Spinal Cord 35:266–274

    Article  PubMed  Google Scholar 

  10. Blaivas JG, Awad SA, Bissada N et al (2005) Urodynamic procedures: recommendations of the urodynamic society I. Procedures that should be available for routine urologic practice. Neurourol Urodyn 1:51–55

    Article  Google Scholar 

  11. Schurch B, Denys P, Kozma CM et al (2007) Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence. Eur Urol 52:850–858

    Article  PubMed  CAS  Google Scholar 

  12. Schulte-Baukloh H, Weiss C, Stolze T et al (2005) Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur Urol 48:984–990

    Article  PubMed  Google Scholar 

  13. Reitz A, Stohrer M, Kramer G et al (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45:510–515

    Article  PubMed  CAS  Google Scholar 

  14. Smith CP, Gangitano DA, Munoz A et al (2008) Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury. Neurochem Int 52:1068–1075

    Article  PubMed  CAS  Google Scholar 

  15. Dixon J, Glosing J (1987) Structure and innervation in the human. In: Torrens M, Morrison JFB (eds) The physiology of the lower urinary tract. Springer, New York, pp 3–22

    Google Scholar 

  16. Brading A (1987) Physiology of bladder smooth muscle. In: Torrens M, Morrison JFB (eds) The physiology of the lower urinary tract. Springer, New York, pp 161–192

    Google Scholar 

  17. Akbar M, Abel R, Seyler TM et al (2007) Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int 100:639–645

    Article  PubMed  Google Scholar 

  18. Kuo HC (2004) Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 63:868–872

    Article  PubMed  Google Scholar 

  19. Kuo HC (2005) Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics. Urology 66:94–98

    Article  PubMed  Google Scholar 

  20. Schurch B, Denys P, Kozma CM et al (2007) Reliability and validity of the incontinence quality of Life questionnaire in patients with neurogenic urinary incontinence. Arch Phys Med Rehabil 88:646–652

    Article  PubMed  Google Scholar 

  21. Hori S, Patki P, Attar KH (2009) Patients’ perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury. BJU Int 104:216–220

    Article  PubMed  Google Scholar 

  22. Grosse J, Kramer G, Stohrer M (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47:653–659

    Article  PubMed  CAS  Google Scholar 

  23. Schulte-Baukloh H, Knispel HH, Stolze T et al (2005) Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology 66:865–870

    Article  PubMed  Google Scholar 

  24. Dressler D, Hallett M (2006) Immunological aspects of botox, dysport and myobloc/neurobloc. Eur J Neurol 13(Suppl. 1):11–15

    Article  PubMed  Google Scholar 

  25. Herrmann J, Geth K, Mall V et al (2004) Clinical impact of antibody formation to botulinum toxin A in children. Ann Neurol 55:732–735

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The source of funding for this research is China National Technology R&G Program, No. 2008BAI50B06.

Author information

Authors and Affiliations

  1. Department of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, 100068, Beijing, China

    Guoqing Chen & Limin Liao

Authors
  1. Guoqing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Limin Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Limin Liao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, G., Liao, L. Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury. Int Urol Nephrol 43, 655–662 (2011). https://doi.org/10.1007/s11255-010-9873-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-010-9873-x

Keywords

Search

Navigation